(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | (Q6)Jun 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -6.65%30.15B | 29.05%69.03B | 33.01%32.3B | 5.03%53.49B | 7.04%38.42B | 7.61%24.28B | 9.52%10.89B | 27.02%50.93B | 33.16%35.89B | 41.23%22.57B |
Operating income | -6.65%30.15B | 29.05%69.03B | 33.01%32.3B | 5.03%53.49B | 7.04%38.42B | 7.61%24.28B | 9.52%10.89B | 27.02%50.93B | 33.16%35.89B | 41.23%22.57B |
Cost of sales | 7.96%-25.86B | -31.14%-59.39B | -37.72%-28.1B | -6.85%-45.28B | -7.82%-32.4B | -8.41%-20.41B | -10.26%-9.1B | -28.70%-42.38B | -35.86%-30.05B | -45.99%-18.82B |
Operating expenses | 7.96%-25.86B | -31.14%-59.39B | -37.72%-28.1B | -6.85%-45.28B | -7.82%-32.4B | -8.41%-20.41B | -10.26%-9.1B | -28.70%-42.38B | -35.86%-30.05B | -45.99%-18.82B |
Gross profit | 2.17%4.29B | 17.52%9.65B | 8.22%4.2B | -3.99%8.21B | 3.07%6.02B | 3.58%3.88B | 5.93%1.79B | 19.32%8.55B | 20.79%5.84B | 21.35%3.75B |
Selling expenses | 1.71%-1.79B | -7.44%-3.7B | -13.22%-1.82B | 13.61%-3.44B | 11.69%-2.54B | 13.53%-1.6B | 15.64%-750M | -14.50%-3.98B | -20.25%-2.87B | -24.08%-1.86B |
Administrative expenses | 2.22%-838M | -16.14%-1.92B | -23.13%-857M | -11.83%-1.65B | -18.88%-1.13B | -13.17%-696M | -15.08%-351M | -4.52%-1.48B | -4.18%-948M | -4.77%-615M |
Research and development expenses | 2.87%-981M | -0.52%-2.13B | -0.90%-1.01B | -0.91%-2.12B | -5.02%-1.55B | -2.14%-1B | 5.49%-465M | -12.44%-2.1B | -15.60%-1.48B | -20.39%-980M |
Impairment and provision | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 69.70%-10M |
-Other impairment is provision | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 69.70%-10M |
Operating interest expense | ---- | ---- | ---- | ---- | 0.81%-367M | -2.10%-243M | 0.00%-120M | -4.77%-461M | ---370M | 6.67%-238M |
Special items of operating profit | -6.14%566M | -24.10%945M | 18.47%603M | -38.00%1.25B | -23.43%879M | -33.29%509M | -79.96%95M | -8.64%2.01B | -6.89%1.15B | -10.86%763M |
Operating profit | 11.90%1.25B | 26.93%2.85B | 32.46%1.12B | -11.62%2.24B | -0.30%1.32B | 4.20%844M | -44.79%196M | 17.23%2.54B | -9.84%1.32B | 6.86%810M |
Financing cost | 8.33%-253M | -20.83%-522M | ---276M | ---432M | ---- | ---- | ---- | ---- | ---- | ---- |
Share of profits of associates | -38.10%-29M | -125.00%-2M | -40.00%-21M | -42.86%8M | -250.00%-9M | -600.00%-15M | -700.00%-6M | -6.67%14M | 50.00%6M | 175.00%3M |
Share of profit from joint venture company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -200.00%-1M |
Earning before tax | 18.03%969M | 27.71%2.32B | -0.97%821M | -28.72%1.82B | -1.43%1.31B | 2.09%829M | -46.63%190M | 17.06%2.55B | 20.35%1.33B | 7.55%812M |
Tax | -24.39%-255M | -35.19%-557M | -3.54%-205M | 29.81%-412M | 4.29%-312M | 1.98%-198M | 72.22%-20M | -70.14%-587M | -23.95%-326M | -10.99%-202M |
After-tax profit from continuing operations | 15.91%714M | 25.52%1.77B | -2.38%616M | -28.40%1.41B | -0.50%994M | 3.44%631M | -40.14%170M | 7.08%1.97B | 19.21%999M | 6.46%610M |
Earning after tax | 15.91%714M | 25.52%1.77B | -2.38%616M | -28.40%1.41B | -0.50%994M | 3.44%631M | -40.14%170M | 7.08%1.97B | 19.21%999M | 6.46%610M |
Minority profit | 5.10%330M | 20.17%697M | 7.53%314M | 75.23%580M | 101.69%476M | 45.27%292M | -11.40%101M | -16.20%331M | -19.45%236M | 10.44%201M |
Profit attributable to shareholders | 27.15%384M | 29.26%1.07B | -10.91%302M | -49.39%827M | -32.11%518M | -17.11%339M | -59.41%69M | 13.47%1.63B | 40.00%763M | 4.60%409M |
Basic earnings per share | 36.49%0.1631 | 34.97%0.4315 | -7.94%0.1195 | -48.53%0.3197 | -31.33%0.1992 | -16.47%0.1298 | -59.22%0.0263 | 26.16%0.6211 | 60.45%0.2901 | 20.75%0.1554 |
Diluted earnings per share | 36.49%0.1631 | 35.05%0.4315 | -7.79%0.1195 | -48.49%0.3195 | -31.44%0.1989 | -10.25%0.1296 | -59.38%0.0262 | 39.52%0.6203 | 95.22%0.2901 | 19.24%0.1444 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data